Member access

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesHot NewsMost Read NewsRecomm.Business LeadersVideosCalendar 

PTC Therapeutics Inc. : PTC THERAPEUTICS PRICES INITIAL PUBLIC OFFERING

06/21/2013 | 05:03am US/Eastern

SOUTH PLAINFIELD, NJ - June 20, 2013 - PTC Therapeutics, Inc. (PTC) today announced the pricing of its initial public offering of 8,372,000 shares of common stock at a public offering price of $15.00 per share, before underwriting discounts. All of the shares in the offering are being sold by PTC. In addition, the underwriters have an option for a period of 30 days to purchase up to 1,255,800 additional shares of common stock from PTC at the public offering price, less the underwriting discount. PTC's common stock has been approved for listing on the NASDAQ Global Select Market and is expected to begin trading under the ticker symbol "PTCT" on June 20, 2013.

J.P. Morgan and Credit Suisse are acting as joint book-running managers for the offering. Cowen and Company is acting as co-lead manager and Wedbush PacGrow Life Sciences as co-manager.

A registration statement relating to these securities was declared effective by the Securities and Exchange Commission on June 19, 2013.

The offering is being made only by means of a prospectus, copies of which may be obtained from J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, New York 11717; telephone: 866-803-9204; or Credit Suisse Securities (USA) LLC, Attn: Prospectus Department, One Madison Avenue, New York, NY 10010; telephone: 800-221-1037; email: newyork.prospectus@credit-suisse.com.

This press release shall not constitute an offer to sell or the solicitation of an offer to buy, nor shall there be any sale of, these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to the registration or qualification under the securities laws of such state or jurisdiction.

ABOUT PTC THERAPEUTICS, INC.

PTC is a biopharmaceutical company focused on the discovery and development of orally administered small-molecule drugs that target post-transcriptional control processes. Post-transcriptional control processes regulate the rate and timing of protein production and are of central importance to proper cellular function. PTC's internally discovered pipeline addresses multiple therapeutic areas, including rare genetic disorders and infectious diseases.

CONTACT

Jane Baj

PTC Therapeutics, Inc.

908-912-9167

jbaj@ptcbio.com

Sheryl Seapy

Pure Communications

sheryl@purecommunicationsinc.com


distributed by
Latest news
Date Title
4m ago APPLE : Time for all Apple products to enter China
4m ago HONG KONG EXCHANGES AND CLEARING : Limited impact from 'HK-SH through train' delay
14m ago Transitional Provisions for the Application of Minimum Reserve Requirements in Lithuania
22m ago GOOGLE 'C' : Executive Sets New Freefall Jump Record
47m ago WESTLAKE CHEMICAL PARTNERS : Announce Third Quarter 2014 Earnings Conference Call
56m agoDJOregon Initiative Seeks Lower Pot Taxes Than Cities Want
57m ago BTU : SHAREHOLDER ALERT: Brodsky & Smith, LLC Announces Investigation of BTU International, Inc. in Connection with the Sale of the Company -BTUI
58m ago EQUITY ALERT : The Rosen Law Firm Files Securities Class Action Against Blue Earth, Inc. -- BBLU
58m ago EQUITY ALERT : The Rosen Law Firm Files Securities Class Action Against iBio, Inc. -- IBIO
1h ago GOOGLE 'C' : executive sets new skydiving record
Latest news
Advertisement
Hot News 
DIGITAL RIVER : Announces Agreement to be Acquired by Investor Group Led by Siris Capital Group for $26.00 per Share in Cash
EDREAMS ODIGEO : Statement responding to BA and Iberia statement
4IMPRINT : Full Year Expectations Underpinned By Strong Third Quarter
ATLANTIS RESOURCES : Raises GBP5.0 Million In Discounted Placing (ALLISS)
MERIT MEDICAL SYSTEMS : posts 3Q profit
Most Read News
5h ago MATSON : Shipping company pleads guilty in molasses spill
5h ago Fannie Mae settles shareholder lawsuit for $170 million
5h ago HEARTLAND EXPRESS : 2014 Q3 Earnings Release
4h ago Google's Pichai to oversee major products and services
5h ago TW TELECOM : Level 3 and tw telecom Receive Federal Communications Commission Approval
Most recommended articles
56m agoDJOregon Initiative Seeks Lower Pot Taxes Than Cities Want
2h ago WEEKLY TRADING FORECAST : FX Traders Prepare for Heavy Volatility on FOMC, GDP and ECB Stimulus
2h ago Dollar and Market Confidence Ride on FOMC Decision
2h ago Look to energy names for global demand clues
2h agoDJPGA Fires Its President
Dynamic quotes  
ON
| OFF